Submitted by pab4011 on July 18, 2023 - 7:51pm
| Title | FGF21 is required for the metabolic benefits of IKKε/TBK1 inhibition.” Journal of Clinical Investigation |
| Publication Type | Journal Article |
| Year of Publication | 2021 |
| Authors | Reilly SM, Abu-Odeh M, Ameka M, Deluca JH, Naber MC, Dadpey B, Ebadat N, Gomez AV, Peng X, Poirier BA, Walk E, Potthoff MJ, Saltiel AR |
| Journal | The Journal of Clinical Investigation |
| URL | https://www.jci.org/articles/view/145546 |